|Articles|December 20, 2001
CBER Recall of Hepatitis A Vaccine
Author(s)BioPharm International Editors
CBER Recall of Hepatitis A Vaccine, Inactivated (VAQTA) Packaged in single-dose prefilled syringes, posted 10 December 2001
Advertisement
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on BioPharm International
1
BioPharma By The Numbers: Batch Failures in Biopharma Manufacturing
2
Charles River Incubator Cohort to Accelerate CGT Development
3
GSK and Oxford BioTherapeutics Drive Antibody-Based Cancer Drug Discovery at Industry Scale
4
Developing Next-Gen Cell Lines Using Targeted Integration
5
